Corbus Pharmaceuticals I...

NASDAQ: CRBP · Real-Time Price · USD
9.25
-0.38 (-3.95%)
At close: Aug 15, 2025, 3:59 PM
9.43
1.95%
After-hours: Aug 15, 2025, 04:56 PM EDT

Corbus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-40.21M -44.6M -42.35M -45.64M
Depreciation & Amortization
-2.74M 640.6K 1.49M 1.64M
Stock-Based Compensation
6.14M 3.47M 5.72M 9.48M
Other Working Capital
-7.18M 3.07M -3.77M -9.74M
Other Non-Cash Items
-1.53M 297.78K 1.62M 950.61K
Deferred Income Tax
n/a n/a n/a 1.08M
Change in Working Capital
-5.58M 4.09M -4.02M -15.7M
Operating Cash Flow
-41.79M -36.1M -37.54M -48.18M
Capital Expenditures
n/a n/a -13.45K -54.17K
Cash Acquisitions
n/a n/a 8.1K 23.9K
Purchase of Investments
-180.8M -33.88M -86.34M -87.27M
Sales Maturities Of Investments
59.49M 69.53M 116.42M 13.88M
Other Investing Acitivies
n/a n/a 30.09K -73.36K
Investing Cash Flow
-121.31M 35.64M 30.07M -73.42M
Debt Repayment
-15.48M -2.87M -533.62K 57.78K
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a -190.9K n/a -1.82M
Financial Cash Flow
166.58M -2.82M -533.62K 60.82M
Net Cash Flow
3.47M -3.28M -8M -60.78M
Free Cash Flow
-41.79M -36.1M -37.56M -48.24M